Several prognostic factors such as tumor size, lymph node involvement, nuclear and histologic grade, and hormone receptor status are commonly used together in predicting the clinical outcome of patients with breast cancer rather than a single parameter. This evidence concerns the gene NR4A1 and breast cancer.